GlobalData provides unique and market-leading data and insights into the infectious disease market. Browse or search our Report Store for the latest comprehensive reports, market data, analysis and survey findings alongside industry information on key companies, markets and financial deals.

Cytomegalovirus (HHV-5) Infections – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Cytomegalovirus (HHV-5) Infections" provides an overview of Cytomegalovirus (HHV-5) Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Cytomegalovirus...

Fungal Infections – Global Clinical Trials Review, H2, 2021

  • $2,500
  • December 2021
GlobalData's clinical trial report, “Fungal Infections" provides an overview of Fungal Infections Clinical trials scenario. This report provides top line data relating to the clinical trials on Fungal Infections. Report...

Respiratory Syncytial Virus (RSV) Infections – Global Clinical Trials Review, H2, 2021

  • $2,500
  • November 2021
GlobalData's clinical trial report, “Respiratory Syncytial Virus (RSV) Infections - Global Clinical Trials Review, H2, 2021" provides an overview of Respiratory Syncytial Virus (RSV) Infections Clinical trials scenario. This report...

Sepsis Therapeutics Market Size, Share & Trends Analysis and Forecast 2021 – 2030

  • $10,995
  • November 2021
Sepsis is a life-threatening condition that occurs when the body's response to an infection causes injury to its own tissues and organs. If not recognized early and managed promptly, it...

Rabies – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Rabies - Global Clinical Trials Review, H2, 2021" provides an overview of Rabies Clinical trials scenario. This report provides top line data relating to the clinical...

Genital Herpes – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Genital Herpes - Global Clinical Trials Review, H2, 2021" provides an overview of Genital Herpes Clinical trials scenario. This report provides top line data relating to...

Herpes Labialis (Oral Herpes) – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Herpes Labialis (Oral Herpes) - Global Clinical Trials Review, H2, 2021" provides an overview of Herpes Labialis (Oral Herpes) Clinical trials scenario. This report provides top...

Syphilis – Global Clinical Trials Review, H2, 2021

  • $2,500
  • October 2021
GlobalData's clinical trial report, “Syphilis - Global Clinical Trials Review, H2, 2021" provides an overview of Syphilis Clinical trials scenario. This report provides top line data relating to the clinical...

Kaposi Sarcoma – Global Clinical Trials Review, H2, 2021

  • $2,500
  • September 2021
GlobalData's clinical trial report, “Kaposi Sarcoma - Global Clinical Trials Review, H2, 2021" provides an overview of Kaposi Sarcoma Clinical trials scenario. This report provides top line data relating to...

Epstein-Barr Virus (HHV-4) Infections – Global Clinical Trials Review, H2, 2021

  • $2,500
  • September 2021
GlobalData's clinical trial report, “Epstein-Barr Virus (HHV-4) Infections - Global Clinical Trials Review, H2, 2021" provides an overview of Epstein-Barr Virus (HHV-4) Infections Clinical trials scenario. This report provides top...